Gelsana Therapeutics, Inc.

Advanced polymer wound dressings for faster healing

San Francisco, United States · Founded 2020 · $7.8M raised

Employees
1–10
Founded
2020
Business Model
B2B
Total Funding
$7.8M
Last Round
$3.5M SeedMar 2026
Rounds
8

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 8 funding rounds and 2 investors for this company. The full record is or through the API.

About

GelSana Therapeutics develops advanced polymer wound dressings for improved healing of chronic and hard-to-treat wounds. Its lead product, Cleragel, is a novel hydrogel dressing that reduces inflammation, prevents bacterial adhesion, and enables sustained drug delivery — addressing diabetic ulcers and other chronic wound conditions.

Summary

Gelsana Therapeutics, Inc. is a Biotech company based in San Francisco, United States, founded in 2020. It has raised $7.8M in total across 8 rounds, most recently a $3.5M Seed round in Mar 2026. Investors include Innosphere Ventures and MedTech Innovator.

Tech & App Stack

6 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

SeedSeed RoundMar 2026
$3.5M

Sign up to see all 8 events

Funding: Pre-Seed through Seed. Amounts, valuations, and investors where available.

Investors

Similar Companies

Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare
Growth EquityTotal funding$5.1BAug 2022
ParexelAcquired

One of the world's largest contract research organizations (CROs), providing end-to-end clinical ...

Raleigh, United States10001+Biotech
Private EquityTotal funding$5.0BJun 2017
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Gelsana Therapeutics, Inc. on Indexed.vc
<a href="https://indexed.vc/companies/gelsana-therapeutics-inc"><img src="https://indexed.vc/api/badge/company/gelsana-therapeutics-inc" alt="Gelsana Therapeutics, Inc. on Indexed.vc" width="260" height="76" /></a>